Latest News On Marijuana

Latest Kaiser Health News Stories

Hemp-Derived Delta-8 Skirts Marijuana Laws and Raises Health Concerns

KHN Original

A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.

Patients With Epilepsy Navigate Murky Unregulated CBD Industry

KHN Original

The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.

Veterans Push for Medical Marijuana in Conservative South

KHN Original

North Carolina claims to be the “Nation’s Most Military Friendly State.” Now veterans are trying to capitalize on this dedication to the troops to persuade lawmakers to pass medical marijuana legislation. It’s an advocacy model that has led to success for pro-cannabis efforts elsewhere.

American Pot Is The Gold Standard. But Canada Leads The Export Game — For Now.

KHN Original

American marijuana has a reputation for being the best in the world. But the federal prohibition on marijuana makes shipments across state lines or overseas a pipe dream. While U.S. firms expect the restrictions to drop in the coming years, they are stuck operating within state borders. That’s left Canadian cannabis growers to dominate the export market, with U.S. firms falling further behind each year.

Los Angeles Vape District A Black-Market Gateway

KHN Original

A seedy section of downtown Los Angeles has become the go-to place for those who trade in wholesale — and sometimes counterfeit — vaping products. As more people fall ill with a mysterious lung disease linked to e-cigarette use, the manufacture and distribution of vaping products face increased scrutiny.